Please login to the form below

Not currently logged in
Email:
Password:

Pharma Perspectives

This page shows the latest Pharma Perspectives news and features for those working in and with pharma, biotech and healthcare.

Power to the people

Power to the people

To progress, pharma needs to think differently about how it conducts patient research and to understand the nuance between research and insight. ... This ‘deep dive’into patients’perspectives does require pharma to shift from its traditional

Latest news

  • Introducing pharma perspectives Introducing pharma perspectives

    Introducing pharma perspectives. Matt de Gruchy outlines the HCC's forthcoming collaboration with PME. ... This need for industry executives and agency staff to work in harmony to conquer the emerging healthcare challenges is what sits behind 'Pharma

  • AbbVie uses art gallery in inflammation campaign AbbVie uses art gallery in inflammation campaign

    With'Perspectives – Art, Inflammation and Me', the pharma company hopes to add a different dimension to the understanding of immune-mediated inflammatory diseases (IMIDs) and their impact. ... week. Perspectives will also visit various art galleries

  • German healthcare reforms

    German healthcare reforms. Payer and pharma perspectives on what the changes mean.

  • Ties that bind

    Ties that bind. Payers give their perspectives on what pharma must do to build lasting, meaningful and mutually beneficial relationships. ... One area in which pharma can add significant value is through connecting stakeholders.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma Perspectives: The agency selection process (part 2) Pharma Perspectives: The agency selection process (part 2)

    Pharma Perspectives: The agency selection process (part 2). AstraZeneca's Samuel Hollis on the evolution of the agency selection process. ... Samuel Hollis is a business unit director at AstraZeneca. In Pharma Perspectives, published in association with

  • Pharma Perspectives: The agency selection process (part 1) Pharma Perspectives: The agency selection process (part 1)

    Pharma Perspectives: The agency selection process (part 1). S&H Group's David Higgins on the evolution of the agency selection process. ... In Pharma Perspectives, published in association with the HCC, senior industry and agency figures address key

  • Pharma perspectives: communications creativity (part 2) Pharma perspectives: communications creativity (part 2)

    Pharma perspectives: communications creativity (part 2). David Higgins from Sudler &Hennessey Group on what it means to be creative in healthcare communications. ... In the PME/PMLiVE series Pharma Perspectives with the HCC senior industry and agency

  • Pharma perspectives: communications creativity (part 1) Pharma perspectives: communications creativity (part 1)

    Pharma perspectives: communications creativity (part 1). AstraZeneca business unit director Samuel Hollis on what healthcare communications creativity means to him. ... In the PME/PMLiVE series Pharma Perspectives with the HCC senior industry and agency

  • The pharma business environment in the US The pharma business environment in the US

    How companies respond to these changes will determine the future of the US pharma market. ... Domestic perspectives:. Overall, domestic companies within the pharma sector are reporting a positive outlook as changes in the pharma industry are seen as

More from intelligence
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics